1.
Callahan D. The WHO definition of health. Pharmacy Ethics, eds SmithM, StraussS. 1973:95-104.
2.
Cohen M. Towards a framework for women's health. Patient Education and Counseling.
1998;33(3):187-96.
3.
Chandra-Mouli V, Svanemyr J, Amin A, Fogstad H, Say L, Girard F, et al. Twenty years
after International Conference on Population and Development: where are we with adolescent
sexual and reproductive health and rights? Journal of Adolescent Health. 2015;56(1):S1-S6.
4.
Glasier A, Gülmezoglu AM, Schmid GP, Moreno CG, Van Look PF. Sexual and reproductive
health: a matter of life and death. The Lancet. 2006;368(9547):1595-607.
5.
Correa S, Petchesky R. Reproductive and sexual rights: a feminist perspective. Culture,
Society and Sexuality: Routledge; 2007. p. 314-32.
6.
Sen G, Batliwala S. Empowering women for reproductive rights. 2000.
7.
Murray CJ, Lopez AD, Organization WH. The global burden of disease: a comprehensive
assessment of mortality and disability from diseases, injuries, and risk factors in
1990 and projected to 2020: summary. 1996.
8.
Khani S, Moghaddam Banaem L, Mohammadi E, Vedadhir A, Hajizadeh E. The most common
sexual and reproductive health needs in women referred to healthcare and triangle
centers of Sari-2013. Journal of Mazandaran University of Medical Sciences. 2014;23(1):41-53.
9.
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology,
pathogenesis and diagnosis. Nature Reviews Endocrinology. 2011;7(4):219.
10.
Yamin AE, Boulanger VM. Embedding sexual and reproductive health and rights in a transformational
development framework: lessons learned from the MDG targets and indicators. Reproductive
Health Matters. 2013;21(42):74-85.
11.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations
from the international evidence-based guideline for the assessment and management
of polycystic ovary syndrome. Human Reproduction. 2018;33(9):1602-18.
12.
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on
women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored
3rd PCOS Consensus Workshop Group. Fertility and sterility. 2012;97(1):28-38. e25.
13.
Bazarganipour F, Taghavi SA, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact
of polycystic ovary syndrome on the health-related quality of life: A systematic review
and meta-analysis. Iranian journal of reproductive medicine. 2015;13(2):61.
14.
Li Y, Li Y, Ng EHY, Stener-Victorin E, Hou L, Wu T, et al. Polycystic ovary syndrome
is associated with negatively variable impacts on domains of health-related quality
of life: evidence from a meta-analysis. Fertility and sterility. 2011;96(2):452-8.
15.
Bearinger LH, Sieving RE, Ferguson J, Sharma V. Global perspectives on the sexual
and reproductive health of adolescents: patterns, prevention, and potential. The lancet.
2007;369(9568):1220-31.
16.
Singh S, Darroch JE, Ashford LS. Adding it up: The costs and benefits of investing
in sexual and reproductive health 2014. 2014.
17.
Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International
journal of social research methodology. 2005;8(1):19-32.
18.
Fleming PS, Koletsi D, Pandis N. Blinded by PRISMA: are systematic reviewers focusing
on PRISMA and ignoring other guidelines? PLoS One. 2014;9(5):e96407.
19.
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the
conduct of narrative synthesis in systematic reviews. A product from the ESRC methods
programme Version. 2006;1:b92.
20.
UNFPA N. Sexual and reproductive health (SRH) needs assessment among Mobile & Vulnerable
Population (MPV) communities in Zimbabwe. Nedico; 2008.
21.
Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of
polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis.
Iranian journal of reproductive medicine. 2015;13(10):591.
22.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological,
reproductive and metabolic manifestations that impacts on health across the lifespan.
BMC medicine. 2010;8(1):41.
23.
Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women
with polycystic ovary syndrome. BJOG: An International Journal of Obstetrics & Gynaecology.
2006;113(10):1148-59.
24.
Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic
ovary syndrome. Trends in Endocrinology & Metabolism. 2002;13(6):251-7.
25.
Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle
East Fertility Society Journal. 2011;16(1):19-37.
26.
Fauser B, Tarlatzis B, Rebar R, Legro R, Balen A, Lobo R, et al. Consensus on womens
health aspects of polycystic ovary syndrome (PCOS). Human Reproduction. 2012;27(1):14-24.
27.
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis
and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice
guideline. The Journal of Clinical Endocrinology & Metabolism. 2013;98(12):4565-92.
28.
Bellver J, Rodríguez-Tabernero L, Robles A, Muñoz E, Martínez F, Landeras J, et al.
Polycystic ovary syndrome throughout a woman’s life. Journal of assisted reproduction
and genetics. 2018;35(1):25-39.
29.
Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse
pregnancy outcomes in women with polycystic ovary syndrome: population based cohort
study. Bmj. 2011;343:d6309.
30.
Li Y, Ruan X, Wang H, Li X, Cai G, Du J, et al. Comparing the risk of adverse pregnancy
outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic
pretreatment. Fertility and sterility. 2018;109(4):720-7.
31.
McDonnell R, Hart RJ. Pregnancy-related outcomes for women with polycystic ovary syndrome.
Women's Health. 2017;13(3):89-97.
32.
Holton S, Kirkman M, Rowe H, Fisher J. The childbearing concerns and related information
needs and preferences of women of reproductive age with a chronic, noncommunicable
health condition: a systematic review. Women's Health Issues. 2012;22(6):e541-e52.
33.
Avery JC, Braunack-Mayer AJ. The information needs of women diagnosed with Polycystic
Ovarian Syndrome–implications for treatment and health outcomes. BMC women's health.
2007;7(1):9.
34.
Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden
of the polycystic ovary syndrome during the reproductive life span. The Journal of
Clinical Endocrinology & Metabolism. 2005;90(8):4650-8.
35.
ZareMobini F, Kazemi A, Farajzadegan Z. A comprehensive mental health care program
for women with polycystic ovary syndrome: protocol for a mixed methods study. Reproductive
health. 2018;15(1):46.
36.
Amiri FN, Tehrani FR, Simbar M, Montazeri A, Thamtan RAM. The experience of women
affected by polycystic ovary syndrome: a qualitative study from Iran. International
journal of endocrinology and metabolism. 2014;12(2).
37.
Kaczmarek C, Haller DM, Yaron M. Health-related quality of life in adolescents and
young adults with polycystic ovary syndrome: a systematic review. Journal of pediatric
and adolescent gynecology. 2016;29(6):551-7.
38.
Mazloomymahmoodabad S, Ardjmandi M, Farajkhoda T. To Evaluate Health-Related Quality
of Life in Women with Polycystic Ovary Syndrome in Yazd, 2014. Toloo-e-behdasht. 2016;14(6):236-46.
39.
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S.
Sexual functioning among married Iranian women with polycystic ovary syndrome. International
journal of fertility & sterility. 2014;8(3):273.
40.
Eftekhar T, Sohrabvand F, Zabandan N, Shariat M, Haghollahi F, Ghahghaei-Nezamabadi
A. Sexual dysfunction in patients with polycystic ovary syndrome and its affected
domains. Iranian journal of reproductive medicine. 2014;12(8):539.
41.
McCook JG, Reame NE, Thatcher SS. Health‐related quality of life issues in women with polycystic ovary syndrome. Journal of
Obstetric, Gynecologic, & Neonatal Nursing. 2005;34(1):12-20.
42.
NASIRI AMIRI F, RAMEZANI TEHRANI F, SIMBAR M, THAMTAN M, ALI R. Concerns of women
with polycystic ovary syndrome: A qualitative study. Iranian Journal of Endocrinology
and Metabolism. 2013;15(1):41-51.
43.
Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. Testosterone and mood dysfunction
in women with polycystic ovarian syndrome compared to subfertile controls. Journal
of Psychosomatic Obstetrics & Gynecology. 2011;32(2):104-11.
44.
Zangeneh FZ, Jafarabadi M, Naghizadeh MM, Abedinia N, Haghollahi F. Psychological
distress in women with polycystic ovary syndrome from Imam Khomeini Hospital, Tehran.
Journal of reproduction & infertility. 2012;13(2):111.
45.
Sanchez N, Jones H. “Less Than A Wife”: A Study of Polycystic Ovary Syndrome Content
in Teen and Women’s Digital Magazines. Journal of medical Internet research. 2016;18(6).
46.
Johnsen S, Dolan SE, Fitch KV, Killilea KM, Shifren JL, Grinspoon SK. Absence of polycystic
ovary syndrome features in human immunodeficiency virus-infected women despite significant
hyperinsulinemia and truncal adiposity. The Journal of Clinical Endocrinology & Metabolism.
2005;90(10):5596-604.
47.
Rezayat F, Hajiaghayi M, Ramezani Tehrani F, Mosaffa N. Increase Risk of Ovarian and
Breast Cancers in Women with PolyCystic Ovarian Syndrome: a Review. Iranian Journal
of Endocrinology and Metabolism. 2016;18(1):54-62.
48.
Shabani Azim F, Dashti N. Review on clinical manifestations and long-term consequences
of polycystic ovary syndrome (PCOS). Laboratory & Diagnosis. 2017;9(36):19-27.